1,494
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Genetic Creutzfeldt-Jakob disease shows fatal family insomnia phenotype

, , , , , , , , & show all
Pages 177-182 | Received 25 Jun 2021, Accepted 10 Aug 2021, Published online: 05 Sep 2021

References

  • He R, Hu Y, Yao L, et al. Clinical features and genetic characteristics of two Chinese pedigrees with fatal family insomnia. Prion. 2019;13(1):116–123. PMID: 31122137.
  • Brown K, Mastrianni JA. The prion diseases. J Geriatric Psychiatry Neurol. 2010;23(4):277. PMID: 20938044.
  • Capellari S, Strammiello R, Saverioni D, et al. Genetic Creutzfeldt–Jakob disease and fatal familial insomnia insights into phenotypic variability and disease pathogenesis. Acta Neuropathol. 2011;121(1):21–37. PMID: 20978903.
  • Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol. 2007;6(5):442–455. PMID: 17434099.
  • D’Aprile P, Tarantino A, Santoro N, et al. Wernicke’s encephalopathy induced by total parenteral nutrition in patient with acute leukaemia: unusual involvement of caudate nuclei and cerebral cortex on MRI. Neuroradiology. 2000;42(10):781–783. PMID: 11110087.
  • Zuccoli G, Siddiqui N, Bailey A, et al. Neuroimaging findings in pediatric Wernicke encephalopathy: a review. Neuroradiology. 2010;52(6):523–529. PMID: 19844698.
  • Stone R, Archer JS, Kiernan M. Wernicke’s encephalopathy mimicking variant Creutzfeldt-Jakob disease. J Clin Neurosci. 2008;15(11):1308–1310. PMID: 18829327.
  • Day E, Bentham P, Callaghan R, et al. Thiamine for Wernicke-Korsakoff syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev. 2004;(1):CD004033. PMID: 14974055. DOI:https://doi.org/10.1002/14651858.CD004033.pub2
  • Lucchinetti CF, Kimmel DW, Lennon VA. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology. 1998;50(3):652–657. PMID: 9521251.
  • Flanagan EP, McKeon A, Lennon VA, et al. Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc. 2010;85(10):881–897. PMID:PMC2947960.
  • Mittal MK, Rabinstein AA, Hocker SE, et al. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care. 2016;24(2):240–250. PMID: 26319044.
  • Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65(4):424–434. PMID:PMC2677127.
  • Geschwind MD, Shu H, Haman A, et al. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97–108. PMID:PMC2647859.
  • Geschwind MD. Rapidly progressive dementia. Continuum (Minneap Minn). 2016;22(2Dementia):510–537. PMID:PMC4879977.
  • Krasnianski A, Sanchez Juan P, Ponto C, et al. A proposal of new diagnostic pathway for fatal familial insomnia. J Neurol Neurosurg Psychiatry. 2014;85(6):654–659. PMID:PMC4033028.
  • Goossens K, van Bruchem-Visser RL. A patient with a ‘typical presentation’ of Wernicke encephalopathy was found to have sporadic Creutzfeldt-Jakob disease. Neth J Med. 2017;75(5): 211–214. PMID: 28653943.
  • Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American academy of neurology. Neurology. 2012;79(14):1499–1506. PMID:PMC3525296.
  • Kim MO, Geschwind MD. Clinical update of Jakob-Creutzfeldt disease. Curr Opin Neurol. 2015;28(3):302–310. PMID: 25923128.
  • Coulthart MB, Jansen GH, Olsen E, et al. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol. 2011;11:133. PMID:PMC3216246.
  • Van Harten AC, Kester MI, Visser PJ, et al. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med. 2011;49(3):353–366. PMID: 21342021.
  • Forner SA, Takada LT, Bettcher BM, et al. Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease. Neurol Clin Pract. 2015;5(2):116–125. PMID:PMC4404282.
  • Gambetti P, Kong Q, Zou W, et al. Sporadic and familial CJD: classification and characterisation. Br Med Bull. 2003;66:213–239. PMID: 14522861.
  • Kim MO, Cali I, Oehler A, et al. Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases. Acta Neuropathol Commun. 2013;1:80. PMID:PMC3880091.
  • Sun L, Li X, Lin X, et al. Familial fatal insomnia with atypical clinical features in a patientwith D178N mutation and homozygosity for Met at codon 129 of the prion protein gene. Prion.2015;9(3):228-235. PMID: 26074146.
  • Gao L P , Shi Q , Xiao K , et al. The genetic Creutzfeldt-Jakob disease with E200Kmutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients[J]. Scientific Reports, 2019;9(1). PMID: 30755683.
  • Gaytan-Garcia S, Gilbert JJ, Deck JH, et al. Jakob-Creutzfeldt disease associated with Wernicke encephalopathy. Can J Neurol Sci. 1988;15(2):156–160. PMID: 3289705.
  • Pietrini V. Creutzfeldt-Jakob disease presenting as Wernicke-Korsakoff syndrome. J Neurol Sci. 1992;108(2):149–153. PMID: 1517746.
  • Nagashima T, Okawa M, Kitamoto T, et al. Wernicke encephalopathy-like symptoms as an early manifestation of Creutzfeldt-Jakob disease in a chronic alcoholic. J Neurol Sci. 1999;163(2):192–198. PMID: 10371084.
  • Bielewicz J, Szczepanska-Szerej A, Ogorek M, et al. Wernicke-Korsakoff syndrome as a rare phenotype of sporadic Creutzfeldt-Jakob disease. Prion. 2018;12(2):143–146. PMID:PMC6016515.
  • Iwasaki Y, Hashimoto R, Saito Y, et al. An autopsied case of MM1-type sporadic Creutzfeldt-Jakob disease with pathology of Wernicke encephalopathy. Prion. 2019;13(1):13–20. PMID:PMC6422394.
  • Bertrand A, Brandel JP, Grignon Y, et al. Wernicke encephalopathy and Creutzfeldt-Jakob disease. J Neurol. 2009;256(6):904–909. PMID: 19252796.